NCT03104790View on ClinicalTrials.gov

Assessment of Viral Shedding in Children Previously in Receipt of Multiple Doses of Live Attenuated Influenza Vaccine (LAIV) Compared to Influenza Vaccine-naïve Controls

PHASE4CompletedINTERVENTIONAL

Enrollment

373

Participants

Timeline

Start Date

October 2, 2017

Primary Completion Date

March 13, 2018

Study Completion Date

March 13, 2018

Conditions

Influenza VaccinationInfluenzaVaccination

Interventions

BIOLOGICAL

Fluenz Tetra (The two groups are defined by immunisation history, all receive the same intervention in the study)

live attenuated influenza vaccine (LAIV)

Trial Locations (3)

Unknown

Gloucestershire primary care, Gloucester

Hertfordshire primary care, Hertford

Imperial Healthcare NHS Trust, London

All Listed Sponsors

lead

Public Health England

OTHER_GOV

NCT03104790 - Assessment of Viral Shedding in Children Previously in Receipt of Multiple Doses of Live Attenuated Influenza Vaccine (LAIV) Compared to Influenza Vaccine-naïve Controls | Biotech Hunter | Biotech Hunter